Company intelligence / Profile preview

Orbia

Ownership: Private
Employees: ~24000
Development stage: Other

Overview

Orbia is a global leader in advanced polymer solutions, infrastructure, precision agriculture, connectivity solutions, and fluor & energy materials. In the health sector, its Koura division supplies low-global-warming-potential propellants for metered-dose inhalers and specialty polymers used in medical equipment like IV bags and tubing. It does not develop drugs or biologics but enables pharmaceutical delivery through its products.

Therapeutic areas: Pulmonology
Industry: Chemicals & Materials

Partnerships

Chiesi GroupOther pharma companies using Koura’s Zephex® line of medical propellants

Beyond the preview

Go deeper on Orbia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbia.

Explore the full profile